Filter By
- Agency-Based Community Benefit (ABCB)
- Behavioral Health Reform and Investment Act Senate Bill 3 (SB3)
- Beneficiary Advisory Council (BAC)
- Child Support Services
- (-) DDSD Provider Enrollment & Relations
- Electronic Benefits Transfer (EBT)
- Employee Abuse Registry (EAR)
- Fraud, Waste, & Abuse
- (-) Health Care Consolidation Oversight Act
- Intermediate Care Facility for Individuals with Intellectual Disabilities (ICF/IID)
- (-) Justice-involved Utilization of State Transitioned Healthcare (JUST Health)
- Marketplace Affordability Programs
- Medicaid Transition Premium Relief Program
- National Guard Premium Assistance
- New Mexico Medicaid Estate Recovery Program
- Ordering, Referring, Prescribing Provider (ORP)
- Refugee Resettlement Program
- Rural Health Care Delivery Fund
- Small Business Health Insurance Premium Relief Initiative
- SNAP Quality Control Reviews
- State Employee Premium Assistance Program
- Sun Bucks
- Supplemental Nutrition Assistance Program (SNAP)
- Turquoise Care
The application process takes approximately 90 days to be completed.
New provider agencies must be in compliance with the HCBS settings requirements prior to being approved to provide waiver services.
Settings Requirements must be addressed in your responses to questions and policies found within the application. To learn more, please visit the Centers for Medicare & Medicaid Services website at: CMS Newsroom Factsheets: Home and Community Based Services
Yes. Per Articles 24 of your Provider Agreement, you are required to obtain a fidelity bond for indemnification of losses occasioned by (1) any fraudulent or dishonest act or acts committed by any of the PROVIDER’S employees or agents acting alone or in collusion with others; and (2) the failure of the PROVIDER or its employees to perform faithfully any duty or to properly account for all monies and property received or entrusted by virtue of the employee’s position or employment. The fidelity bond shall be in an amount equal to twenty five percent 25% of the total Provider Agreement amount unless the Provider Agreement amount is less than one hundred thousand dollars $100,000.00 per year. In such cases a minimum bond of ten thousand dollars $10,000.00 will be sufficient and must name the DEPARTMENT (i.e., State of New Mexico Health Care Authority) as a loss payee.
Per Article 25 of your Provider Agreement, you are required to obtain liability insurance, naming the State of New Mexico Health Care Authority as an additional insured with minimum limits of coverage: One million dollars ($1,000,000.00) per occurrence, single limit covering bodily injury and property damage. For Provider Agreements under one hundred thousand dollars ($100,000.00), the PROVIDER’S limits may be reduced to a single limit of one hundred thousand dollars ($100,000.00). The PROVIDER shall submit a copy of the liability insurance to the DEPARTMENT within thirty (30) days of the effective date of this Provider Agreement.
Insurance policies are to be sent to the Provider Enrollment Relations Unit annually to Tammy.Barth@hca.nm.gov or via fax at (505) 476-8894.
No, however, the Provider Enrollment Relations Unit (PERU) maintains licensures for all licensed professionals, education requirements and resumes for case managers, community supports coordinators, and consultants.
If your agency has hired a new subcontractor, please send a copy of their license and/or education requirements and their start date to Tammy.Barth@hca.nm.gov. If you have lost a subcontractor, please contact Tammy, so she can update your record.
Licenses must be submitted to the PERU annually.
Yes. Please send in a list of your Board of Directors to include their name, address, phone number and email address to Tammy.Barth@hca.nm.gov or via fax to (505) 476-8894
No. PERU will send out a DDSD Distribution email to providers at least four (4) months prior to February 15th, which contains the web links to submit the annual report information.
Yes. New Mexico Medicaid Providers are required to obtain a business license for each of the counties/cities you provide services in. The license must be submitted annually to the YES.NM portal. Failure to maintain and submit your business license(s) will result in the termination of your Medicaid number.
The Primary Freedom of Choice (PFOC) form is presented to participants newly allocated to a waiver program and is signed by the participant selecting a DD or MF case manager.
The Secondary Freedom of Choice (SFOC) form is utilized by case management provider agencies to present to participants when selecting DD or MF services.
All licensed hospitals and certain health care provider organizations (as defined in the legislation) proposing a merger, acquisition, or change in majority ownership/control must submit a Transaction Notice to DHI before closing.
The Health Care Consolidation Act applies to any “transaction,” defined as:
1. A merger of one hospital into another;
2. An acquisition of a hospital by another entity; or
3. A change of control of hospital ownership or real estate.
You’ll have 30 days from the initial filing to respond to any requests for missing information. A submission becomes “complete” once HCA has received all required documents, exhibits, and fees.
You can still submit written comments through the end of the comment period. All submissions—oral or written—are given equal weight in HCA’s review.
The Health Care Consolidation Oversight Act authorizes HCA to retain specialized consultants—such as actuaries, financial analysts, or legal experts—to assist with complex transaction reviews. The hospital (or transaction parties) is responsible for reimbursing the HCA’s actual costs for these services.
If HCA denies or conditions your transaction, you may request a contested-case hearing under the Uniform Licensing Act (U.L.A.) within 30 days of the decision notice.
Yes. All documents you file with HCA are treated as confidential under the Health Care Consolidation Oversight Act. If you believe certain exhibits should remain proprietary, clearly mark them “CONFIDENTIAL” and file a redacted public version.
Once your submission is complete, HCA has 120 days to issue a decision. Complex transactions or those flagged as “urgent” may follow an accelerated schedule at HCA’s discretion.
For three years following your transaction, you’ll submit yearly updates on financial performance, service volumes, community benefit activities, and any material changes—using the format HCA provides. You can fill out and submit the report form HERE. You will also need to include THIS FORM in your submission.
You can fill out the annual report form HERE. You will also need to fill out and inlcude THIS FORM in the submission.
Under the Health Care Consolidation Oversight Act, HCA may impose administrative fines on hospitals or transaction parties that knowingly violate filing requirements, proceed with a transaction without approval, or fail to comply with conditions. Fines are assessed on a per‑bed or per‑member basis (as specified in the administrative rules) and revenues are directed to the New Mexico School Fund.
You can find a full list of definitions of terms contained in the act HERE.
Yes. The Health Care Consolidation Oversight Act includes safeguards for individuals who report improper or undisclosed transactions. Whistleblowers may submit information confidentially to the HCA and are protected from retaliation. Any fine revenue collected from violations stemming from a whistleblower report also supports the School Fund.
Yes. HCA requires any participating pharmacy (on-site or community-based) to enroll and bill as a Medicaid pharmacy (separate from the medical provider) and to follow billing and claims processes, including all real-time or batched billing/claims requirements and prior authorization (PA) requirements (if applicable), that match current fee-for-service (FFS) processes.
Carceral facilities can bill for medications as medical claims when the medications are provided by the medical provider rather than dispensed directly from the pharmacy. For example, if a CDC purchases stock medications for Medication Assisted Treatment (MAT) and a qualified provider administers the treatment, the medications and any applicable services (e.g., evaluation or counseling) should be billed as a medical claim.
Facility staff may not transfer bulk medications into individual packages that do not meet state and federal prescribing standards (e.g., pill envelopes) for individuals to utilize upon release. Only medications that are labeled for a specific patient and fulfilled by a licensed pharmacist (including through a licensed onsite pharmacy) according to state and federal prescribing standards meet the medications-in-hand requirement.
No. Medicaid should only be billed for the portion of the bulk medication that is provided to the Medicaid member.
No. Medications must follow the Medicaid formulary, as identified by HCA’s preferred drug list (PDL). While updates to the PDL will be made on a regular basis, Medicaid-enrolled pharmacies should be up to date on covered drugs.
Yes. pharmacy providers are required to submit claims through the point-of-sale system. The point-of-sale system provides relevant drug utilization information that the pharmacist must consider before dispensing a drug. Pharmacies must follow the NM FFS Payer Sheet. The BIN for JUST Health Plus members is 028165, and pharmacy software systems must be updated accordingly so that patient profiles can reflect the new BIN. Additionally, pharmacies must have POS equipment capable of billing D.0 transactions to ensure claims can be received, processed, and sent for payment in the Turquoise Care System.
Yes. Carceral facilities with 340B-acquired medications must identify 340B participation and pricing on claims by using modifiers “UD” or “08” when billing Medicaid for the applicable medications. Please refer to Provider Supplement 20-04 for further instructions on billing for 340B-acquired medications.
HCA expects the ordering provider to determine clinical appropriateness of a new prescription. Providers have the option of overriding a “Fill too Soon” rejection. If utilization information indicates that the member has an adequate supply of the medication or that the quantity being dispensed is excessive, the pharmacist is responsible for resolving the issue by seeking an authorization to dispense the drug, if necessary.
The requirement is to provide up to a 30-day supply of the medications in-hand, as clinically appropriate except as outlined below. HCA expects prescribers to use their clinical judgement when determining the appropriate amount of medication to provide upon release.